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Abstract 
Background: Actinomycete genome sequencing has disclosed a large number of cryptic secondary metabolite bio-
synthetic gene clusters. However, their unavailable or limited expression severely hampered the discovery of bioac-
tive compounds. The whiB-like (wbl) regulatory genes play important roles in morphological differentiation as well as 
secondary metabolism; and hence the wblAso gene was probed and set as the target to activate cryptic gene clusters 
in deepsea-derived Streptomyces somaliensis SCSIO ZH66.
Results: wblAso from deepsea-derived S. somaliensis SCSIO ZH66 was inactivated, leading to significant changes of 
secondary metabolites production in the ΔwblAso mutant, from which α-pyrone compound violapyrone B (VLP B) was 
isolated. Subsequently, the VLP biosynthetic gene cluster was identified and characterized, which consists of a type 
III polyketide synthase (PKS) gene vioA and a regulatory gene vioB; delightedly, inactivation of vioB led to isolation of 
another four VLPs analogues, among which one was new and two exhibited improved anti-MRSA (methicillin-resist-
ant Staphylococcus aureus, MRSA) activity than VLP B. Moreover, transcriptional analysis revealed that the expression 
levels of whi genes (whiD, whiG, whiH and whiI) and wbl genes (wblC, wblE, wblH, wblI and wblK) were repressed by 
different degrees, suggesting an intertwined regulation mechanism of wblAso in morphological differentiation and 
secondary metabolism of S. somaliensis SCSIO ZH66.
Conclusions: wblA orthologues would be effective targets for activation of cryptic gene clusters in marine-derived 
Streptomyces strains, notwithstanding the regulation mechanisms might be varied in different strains. Moreover, the 
availability of the vio gene cluster has enriched the diversity of type III PKSs, providing new opportunities to expand 
the chemical space of polyketides through biosynthetic engineering.
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Background
Given marine environmental conditions are extremely 
different from the terrestrial environment, marine actino-
mycete strains have become an important source of phar-
macologically active compounds [1]. Recently, microbial 
genome sequencing has brought to light a large number 
of cryptic secondary metabolite biosynthetic gene clus-
ters, demonstrating the tremendous genetic potentials 
for producing secondary metabolites, which fundamen-
tally refreshed the way for natural product discovery [2, 
3]. However, most of these biosynthetic pathways are 
not expressed or only expressed in a very low titer under 
ordinary laboratory conditions, which severely hampered 
the discovery of bioactive compounds. Thus activation of 
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cryptic gene clusters has become a tempting and rapidly 
developing field [4–6].
The control of antibiotic biosynthesis involves com-
plex regulatory cascades and intertwined networks, and 
many of them are coordinately regulated together with 
the morphological differentiation [5, 7]. In general, reg-
ulators are classified as pathway-specific regulator (or 
cluster-situated regulator) and global regulator (or pleio-
tropic regulator) per their modes of action [5]. Among 
them, the whiB-like (wbl) regulatory genes have received 
much attention due to their diverse biological roles, 
such as in morphological differentiation and secondary 
metabolism [8, 9]. Wbls are small cytoplasmic proteins 
confined to actinobacteria, which contain four conserved 
cysteine residues coordinating an Fe-S cluster [8, 10]. The 
chromosome of Streptomyces coelicolor A3(2) contains 
11 wbl genes: whiB and whiD genes are involved in spor-
ulation; wblA controls major development transitions; 
wblC mutant was hypersensitive to a wide range of anti-
biotics; inactivation of wblE was lethal; no obvious effects 
were observed when the other six wbl genes (wblH, -I, 
-J, -K, -L, -M) were inactivated [8]. Notably, wblA and its 
homologues have been reported to serve as global regu-
lators for the biosynthesis of various antibiotics, mostly 
in a negative manner (such as for actinorhodin [8], tau-
tomycetin [11] and doxorubicin [12]); conversely, it was 
found to exert dual function in antibiotic biosynthesis in 
Streptomyces chattanoogensis L10 [13] and Streptomyces 
ansochromogenes 7100 [14] as well.
In our efforts to discover novel natural products from 
marine Streptomyces strains by using genome mining 
strategy, wblAso gene was set as the target to activate 
cryptic gene clusters in the deepsea-derived Strepto-
myces somaliensis SCSIO ZH66, leading to significant 
changes of secondary metabolites production in the 
ΔwblAso mutant, from which α-pyrone compound vio-
lapyrone B (VLP B, 1, Fig. 1) was isolated and identified. 
VLPs were first isolated from Streptomyces violascens 
YIM 100525 obtained from Hylobates hoolock feces, and 
were reported to inhibit the growth of Bacillus subtilis 
and Staphylococcus aureus [15]. Simultaneously, VLPs 
were also named as presulficidins, which serve as sulfate 
donors relaying sulfonate from 3′-phosphoadenosine 
5′-phosphosulfate (PAPS) to caprazamycin [16].
Pyrones are usually assembled by type III polyketide 
synthases (PKSs) [16–20], which are homodimeric keto-
synthases that catalyze condensation of one to several 
molecules of extender substrate onto a starter substrate 
through iterative decarboxylative Claisen condensation 
reactions [21]. Notably, type III PKSs usually exhibit 
broad substrate promiscuity, and can recognize unnatural 
substrates to generate novel unnatural products, which 
renders them excellent candidates for enzymatic engi-
neering to expand chemical space of polyketides [22, 23]. 
Several pyrone-encoding type III PKS have been identi-
fied. For instance, BpsA synthesizes of triketide pyrones 
from long-chain fatty acyl-CoA thioesters as starter 
substrates and malonyl-CoA as extender substrate in B. 
subtilis [17]; Gcs catalyzes the condensation of an acyl 
carrier protein (ACP) ester of β-keto acid and ethylmal-
onyl-CoA to form germicidins in S. coelicolor A3(2) [18, 
23]; DpyA catalyzes the synthesis of alkyldihydropyrones 
using β-hydroxyl acid thioesters as starter substrates in 
Streptomyces reveromyceticus [19]; ArsC accepted sev-
eral acyl-CoAs with various lengths of the side chain as a 
starter substrate to give corresponding alkylpyrones [20]; 
Cpz6 was demonstrated to encode presulficidins in vivo 
putatively from CoA- or ACP-activated iso-acyl starter 
units as well as one malonyl and one methylmalonyl unit 
in Streptomyces sp. MK730–62F2 [16].
Herein, VLP B (1) was found via inactivation of the 
global regulatory gene wblAso from deepsea-derived S. 
somaliensis SCSIO ZH66; the type III PKS gene vioA 
encoding VLP was then identified; subsequently, the 
VLP biosynthetic gene cluster was characterized, lead-
ing to isolation of another four VLPs compounds (2–5), 
among which one was new (3) and notably two (4 and 5) 
exhibited improved anti-MRSA (methicillin-resistant S. 
aureus, MRSA) activity than 1.
Results
Inactivation of wblAso led to significant enhancement 
of VLP B production
As wblA and its orthologous genes were reported to be 
down-regulators for secondary metabolism in Strepto-
myces strains [11, 12, 24, 25], the orthologous gene des-
ignated wblAso was probed from S. somaliensis SCSIO 
ZH66 and was set as a target for activating cryptic 
gene clusters. WblAso exhibited 85  % identity to WblA 
(CAB43030.1) from S. coelicolor A3(2) with a highly 
conserved Cys-X21-Cys-X2-Cys-X5-Cys motif, which 
coordinate a redox–sensitive iron-sulphur cluster [10]. 
Gene inactivation was performed to detect its impact 
Fig. 1 The chemical structures of violapyrones (VLPs 1-5). 1, VLP B; 2, 
VLP A; 3, VLP J; 4, VLP C; 5, VLP H. 3 is a novel VLP analogue isolated 
from the ΔvioB mutant
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on production of secondary metabolites in S. somalien-
sis SCSIO ZH66. The ΔwblAso mutant was obtained as 
described in the “Methods” section. After confirmation 
by PCR analysis (Additional file 1: Figure S1), fermenta-
tions were carried out and the accumulated metabolites 
were analyzed by high-pressure liquid chromatography 
(HPLC). As shown in Fig. 2a, the profile of the ΔwblAso 
mutant (panel ii) substantially changed and productions 
were enhanced compared to those in the wild-type strain 
(panel i), indicating that WblAso functions as a global 
negative regulator for secondary metabolism in S. soma-
liensis SCSIO ZH66. Compound 1 at retention time of 
33.1  min, which was a significantly enhanced peak (by 
about fivefold) at wavelength of 290 nm, was then puri-
fied and subject to structural analysis. The UV spectrum 
of 1 displayed λmax at 290  nm (Additional file  1: Figure 
S2A), and the chemical formula of 1 was determined 
to be C13H2O3 by high-resolution electrospray mass 
spectrometry (HR-ESI–MS) (m/z 225.1483 [M  +  H]+, 
calcd 225.1491) (Additional file  1: Figure S2B). The 1H 
NMR data of 1 was further recorded (Additional file  1: 
Figure S2C), leading to its identification as antibiotic 
VLP B (Fig. 1) by comparison of all the above data with 
those previously reported [15]. VLP B was also named 
as presulficidin A, which relays sulfonate from PAPS to 
caprazamycin [16].
Identification of the type III PKS gene involved in VLP B 
biosynthesis
To identify the VLP biosynthetic gene cluster, bioin-
formatic analysis of the S. somaliensis SCSIO ZH66 
genome was performed, revealing the presence of two 
type III PKS genes, pksIII-1 and pksIII-2. BlastP searches 
against the GenBank nr database revealed that PksIII-1 
exhibited 72  % identity to the 1,3,6,8-tetrahydrox-
ynaphthaene synthase (THNS) from S. coelicolor A3(2) 
(WP_011027653.1), and PksIII-2 displayed highly homol-
ogy (95 % identity) to a putative THNS from Streptomy-
ces sp. W9 (WP_012840496.1, Table 1). Further sequence 
alignment of PksIII-2 with reported pyrone synthases 
indicated that PksIII-2 exhibited 53  % identity to Cpz6 
and 36  % identity to DpyA (BAQ19510.1), suggesting 
PksIII-2 might encode VLP B in S. somaliensis SCSIO 
ZH66. Both pksIII-1 and pksIII-2 were inactivated, result-
ing in ΔpksIII-1 and ΔpksIII-2 mutants (Additional file 1: 
Figure S3 and S4). HPLC analysis of their fermentation 
products showed that ΔpksIII-2 failed to accumulate 1 
(Fig. 3 panel iii), while the ΔpksIII-1 mutant (Fig. 3 panel 
ii) produced the same little amount of 1 as that of the 
wild type strain (Fig. 3 panel i). This result demonstrated 
that it is pksIII-2 that is involved in VLP B biosynthesis, 
and thus, pksIII-2 was renamed as vioA.
Characterization of the vio gene cluster
We then analyzed the surrounding sequences of vioA, 
and found that this gene is situated in a circular plas-
mid with the size of ~85 kb. Adjacent to vioA, a regula-
tory gene vioB was found, which displayed 94 % identity 
to an unknown regulator from Streptomyces sp. W9 
(WP_012840387.1); Orf1-Orf2 and Orf(-1)-Orf(-3) are 
hypothetical proteins with unknown functions (Fig.  4, 
Table 1). Gene inactivation was performed to investigate 
Fig. 2 Comparisons of the wild-type strain and the mutant strain ΔwblAso. a HPLC traces of the fermentation broths from the wild-type strain (i) and 
the mutant strain ΔwblAso (ii). “1″ indicates the accumulated compound VLP B by ΔwblAso. b The scanning electron micrographs of the wild-type 
strain (i) and the mutant strain ΔwblAso (ii) after incubation on MS plate at 30 °C for 4 days
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their functions (Additional file  1: Figure S5–S7). As 
shown in Fig.  3, inactivation of vioB led to production 
enhancement of 1 by about eightfold (panel iv), suggest-
ing it serves as a negative regulator; while inactivation 
of orf1 (panel v) and orf(-1-2) (panel vi) had no obvious 
impacts on 1 production, indicating that they are prob-
ably beyond the gene cluster. Therefore, the vio gene clus-
ter consists of only two genes, the structural gene vioA 
and the regulatory gene vioB.
Identification of VLP analogues with improved anti‑MRSA 
activity
Careful analysis of the ΔvioB mutant revealed that a few 
more VLP analogues were accumulated as well in addi-
tion to 1 (Fig. 3, panel iv). Therefore, large scale fermen-
tations were performed, leading to isolation of another 
4 VLPs (2–5) (Fig.  1). The molecular formula of 3 was 
C12H18O3, as determined by HR-ESI–MS (m/z 211.1328 
[M + H]+, calcd 211.1334) (Additional file 1: Figure S8A), 
having less CH2 unit than that of 1. Full sets of 1D and 
2D NMR spectra of 3 were acquired, thereby allowing us 
to complete its structure assignments (Table  2; Fig.  5a, 
Additional file 1: Figure S8). According to the COSY and 
HMBC correlations, 3 has the same 3-methyl-4-hydroxy-
α-pyrone backbone as that in 1, and the side chain at C-6 
was assigned as hexyl (Fig. 5a). Thus, 3 was identified to 
be a novel VLP analogue, named VLP J (Fig.  1). Com-
pounds 2, 4 and 5 were identified as VLP A, VLP C and 
VLP H, respectively, by comparison of their HR-ESI–MS 
and 1H NMR data with those of reported (Additional 
file 1: Figure S9–S11) [15, 26]. Inspection of the structure 
of VLPs 1–5 suggests that they are probably assembled 
from different CoA- or ACP-tethered β-keto acids from 
Table 1 Proposed functions of proteins encoded by the vio biosynthetic gene cluster in S. somaliensis SCSIO ZH66
Protein Size (aa) Proposed function Homologs
Protein/organism Accession no. (identity/similarity %)
Orf(-3) 88 Hypothetical protein pCQ3_109/Streptomyces sp. W9 WP_012840495.1 (65/70)
Orf(-2) 63 Hypothetical protein SVEN_2103/Streptomyces venezuelae ATCC 10712 WP_015033307.1 (60/66)
Orf(-1) 70 Hypothetical protein pCQ4.14/Streptomyces sp. W75 WP_015060953.1 (50/52)
VioA 350 Type III PKS pCQ3.110c/Streptomyces sp. W9 WP_012840496.1 (95/97)
VioB 272 XRE-family regulator pCQ4.19c/Streptomyces sp. W75 WP_015060958.1 (95/95)
Orf1 158 Hypothetical protein pCQ3.4c/Streptomyces sp. W9 WP_012840390.1 (61/62)
Orf2 76 Hypothetical protein pCQ4.20c/Streptomyces sp. W75 WP_015060959.1 (31/34)
Fig. 3 HPLC traces of the fermentation broths from S. somaliensis 
SCSIO ZH66 strains. (i) the wild-type strain; (ii) ΔpksIII-1; (iii) ΔvioA; (iv) 
ΔvioB; (v) Δorf1; (vi) Δorf(-1-2)
Fig. 4 Genetic organization of the vio gene cluster. Proposed 
functions of individual open reading frames are coded with various 
patterns and summarized in Table 1
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branched-chain (for 1, 2, 4 and 5) or straight-chain (for 
3) fatty acid metabolism and methylmalonyl CoA via 
Claisen condensation.
Furthermore, the anti-MRSA bioactivities of VLPs 1–5 
were investigated, and the result revealed that all of them 
with the exception of 2 showed inhibition against MRSA 
at the concentration of 100 μg/well; compound 5 with a 
minimum inhibitory concentration (MIC) value of 25 μg/
mL gave the best activity among the VLPs tested (Fig. 5b, 
Additional file  1: Table S1). These results demonstrated 
that the polarity of the VLPs, which are mostly up to the 
length of alkyl side chains, plays an essential role for their 
anti-MRSA activity.
Effects of wblAso gene inactivation on the vio gene cluster
To detect the effects of wblAso on the expression of 
the vio gene cluster, the transcription levels of vioA 
and vioB were analyzed by quantitative real-time RT-
PCR (qPCR). As shown in Fig.  6a, transcription of 
vioB was substantially reduced in the ΔwblAso mutant 
in comparison to the wild-type strain during fermen-
tation; simultaneously, expression of vioA was obvi-
ously enhanced, suggesting that activation of the vio 
gene cluster was probably achieved via repression of 
vioB. We next set out to determine whether WblAso 
regulated the vio gene cluster directly. To this end, 
we performed electrophoretic mobility shift assay 
(EMSA) to detect the binding ability of WblAso to the 
promoter regions of vioA and vioB under anaerobic 
conditions; however, no binding was observed (data 
not shown).
Effects of wblAso inactivation on morphology of S. 
somaliensis SCSIO ZH66
Moreover, the effects of wblAso inactivation on mor-
phological development were investigated, and the 
phenotype of the ΔwblAso mutant was compared to the 
wild-type strain on mannitol-soy flour (MS) medium. 
While the wild-type strain sporulated well when incu-
bated on MS plate at 30  °C for 4  days, the ΔwblAso 
mutant defected in sporulation at the same condi-
tions (Additional file  1: Figure S12). Scanning elec-
tron microscopy of the surfaces of the strains revealed 
abundant spore chains of the wild-type strain (Fig. 2b, 
panel i), in contrast, thin and sparse aerial hyphae of 
the ΔwblAso mutant (Fig.  2b, panel ii), consistent with 
previous observations in other Streptomyces strains 
[8, 13, 14]. We further evaluated the transcription lev-
els of whi genes as well as other wbl genes. As shown 
in Fig.  6b, the transcription of whiD and whiH was 
almost abolished in the ΔwblAso mutant; the transcrip-
tion levels of whiG and whiI were severely decreased 
to ~6  % of the wild-type levels; conversely, only slight 
difference were observed for the transcription levels of 
whiA (~85  % of the wild-type level) and whiB (~82  % 
of the wild-type level). Interestingly, the transcription 
levels of the other wbl genes (wblC, wblE, wblH, wblI 
and wblK) were also significantly decreased to ~5–55 % 
of the wild-type levels (Fig. 6c). These findings implied 
that wblAso served as a multifunctional regulator via a 
very complex network involved in whi genes as well as 
other wbl genes.
















δH (J in Hz) δC
1 – 165.2
2 – 95.5
3 1.71 (s) 8.3
4 – 166.7
5 5.91 (bs) 100.2
6 – 161.9
7 2.37 (t, 7.5) 32.6
8 1.51 (m) 26.1
9 1.27 (m) 27.6
10 1.26 (m) 30.9
11 1.26 (m) 21.7
12 0.85 (t, 6.5) 13.7
Fig. 5 Correlations of compound 3 and bioassays of VLPs. a Key 
HMBC and COSY correlations of 3 in DMSO-d6. b Antibacterial activity 
of VLPs against MRSA. 100 µg of each compound dissolved in metha-
nol was added. Inhibition zones were observed after incubation at 
37 °C for 20 h; methanol has no impact on the growth of MRSA
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Discussion
Manipulation of global regulators was one of the effec-
tive strategies for activation of cryptic secondary 
metabolite biosynthetic gene clusters [5, 6]. However, 
the orthologues of a specific regulator can play distinct 
roles in different biological backgrounds. Marine micro-
organisms have been endowed with unique physiologi-
cal functions, and thereby unusual metabolic pathways 
during evolution in specific ecological environments [1], 
indicating their underlying regulation mechanisms might 
be unique as well. In the present study, the global regula-
tory gene wblAso was discerned from deepsea-derived S. 
somaliensis SCSIO ZH66, and was then deleted to acti-
vate cryptic gene clusters, leading to identification of 
anti-MRSA compound VLP B and thereafter its encoding 
gene cluster.
So far, the regulatory mechanisms of WblA and its 
orthologues in antibiotics biosynthesis are still unknown 
[13, 14]. WblAs all harbor a conserved helix-turn-helix 
DNA-binding motif, indicating they probably function 
by binding the promotor regions of the target genes. 
However, no evidences have been obtained to support 
their binding abilities to antibiotic biosynthetic genes 
[13]. Further efforts need to be devoted to clarify their 
mechanisms executing regulation of antibiotics biosyn-
thesis. In Streptomyces species, production of secondary 
metabolites is closely coordinated with morphological 
differentiation [5, 7]. Inactivation of wblA and its ortholo-
gous genes had effects on both processes [8, 13, 14], and 
hence the transcription levels of whi genes as well as 
other wbl genes were investigated in this study (Fig.  6). 
Interestingly, transcription evaluation of the whi genes 
in the ΔwblAch mutant suggested whiB, whiH and whiI 
were nearly not transcripted; the expression of whiA was 
decreased to about ~20 % of the wild-type level; on the 
contrary, the transcription level of whiD was increased 
slightly [13]. However, our result revealed that transcrip-
tion levels of not only whiH and whiI but also whiD and 
whiG were all severely decreased in the ΔwblAso mutant 
compared to those in the wild-type strain; conversely, the 
expression of whiA and whiB was only decreased slightly 
(Fig. 6b). The different impacts caused by inactivation of 
wblA orthologues probably implied their varied regula-
tion mechanisms in different strains. It is worth to men-
tion that the transcription levels of other wbl genes in the 
ΔwblAso mutant were also decreased by different degrees 
(Fig. 6c), suggesting wblAso probably interacts with other 
wbl genes as well. Thus, we could speculate that wblAso 
is a multifunctional regulator with an intertwined and 
sophisticated mechanism.
Although both Cpz6 and VioA catalyze the forma-
tion of presulficidin A/VLP B, the genetic contexts of 
cpz6 and vioA are totally different: cpz6 is situated in the 
caprazamycin biosynthetic gene cluster, and vioA lies in 
the vio gene cluster consisting of only two genes; in addi-
tion, VioA encodes VLPs with different types and ratios 
from presulficidins synthesized by Cpz6 [16]. These facts 
Fig. 6 Effects of wblAso inactivation on the expression levels of the 
vio (a), whi (b) and wbl (c) genes. For the vio genes, the transcription 
levels were detected at 3, 5 and 7 days in the wild-type strain and 
the mutant strain ΔwblAso cultured in fermentation medium at 30 °C. 
For the whi and wbl genes, the transcription levels were detected in 
the wild-type strain and the ΔwblAso mutant grown on MS plates at 
30 °C for 4 days. The transcription level of hrdB was used as an internal 
control. Error bars indicated standard deviations (n = 3)
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suggest VLPs might serve different biological functions in 
S. somaliensis SCSIO ZH66 from presulficidins in Strep-
tomyces sp. MK730–62F2, which relay sulfonate from 
PAPS to caprazamycin [16]. The different types and ratios 
of the products encoded by Cpz6 and VioA might be dic-
tated by their different substrate preference as well as 
substrate availability in different biological backgrounds.
Here, for the first time, VLPs were shown to display 
anti-MRSA activity (Fig. 5b). As compounds 1–5 all have 
the same 3-methyl-4-hydroxy-α-pyrone backbone, the 
differences in their anti-MRSA activity can be ascribed 
to the influence of the alkyl side chain at C-6 (Fig.  1). 
As shown in Fig.  5b, the anti-MRSA activity increased 
with decrease in the polarity of the compounds, suggest-
ing that the lipophilic nature of the alkyl chain plays an 
important role for the activity. These findings pointed 
out prospective directions for bioactivity improvement 
of VLPs. Further exploration of substrate promiscuity of 
VioA towards unnatural malonyl-CoA analogues would 
provide more opportunities to engineer chemical diverse 
polyketides using rational approaches.
Conclusions
A plasmid-situated type III PKS gene cluster was acti-
vated by deletion of the wblAso gene in deepsea-derived 
S. somaliensis SCSIO ZH66, leading to isolation of anti-
MRSA α-pyrone compound 1. Further identification 
and characterization of the vio gene cluster resulted in 
one novel VLP analogue (3) and two VLPs analogues (4 
and 5) with improved anti-MRSA bioactivity than that 
of 1. Therefore, wblA orthologues would be effective 
targets for activation of cryptic gene clusters in marine-
derived Streptomyces strains. In addition, the availability 
of the vio gene cluster has enriched the diversity of type 
III PKSs, providing additional opportunities to biosyn-
thetically engineer chemical diverse polyketides for drug 
development.
Methods
Bacterial strains, plasmids, and culture conditions
All strains and plasmids used in this study are listed in 
Additional file  1: Table S2. Escherichia coli DH5α was 
served as the host for general subcloning [27]. Escheri-
chia coli Top10 (Invitrogen, Carlsbad, La Jolla, CA, USA) 
was used as the transduction host for cosmid library con-
struction. Escherichia coli ET12567/pUZ8002 [28] was 
used as the cosmid donor host for E. coli-Streptomyces 
intergenic conjugation. Escherichia coli BW25113/pIJ790 
was used for λRED-mediated PCR-targeting [29]. The S. 
somaliensis SCSIO ZH66 (CGMCC NO. 9492) was iso-
lated from the deep sea sediment collected at a depth 
of 3536 meters of the South China Sea (120° 0.250′E; 
20° 22.971′N), and has been described previously [30]. 
E. coli strains were routinely cultured in Luria–Bertani 
(LB) liquid medium at 37  °C, 200 rpm, or LB agar plate 
at 37 °C. Streptomyces strains were grown at 30 °C on MS 
medium for sporulation and conjugation, and were cul-
tured in tryptic soy broth (TSB) medium for genomic 
DNA preparation. Fermentation medium consists of 1 % 
soluble starch, 2  % glucose, 4  % corn syrup, 1  % yeast 
extract, 0.3 % beef extract, 0.05 % MgSO4·7H2O, 0.05 % 
KH2PO4, 0.2 % CaCO3, and 3 % sea salt, pH = 7.0, which 
was further supplemented with 1.5 % XAD-16 resin when 
fermenting the ΔwblAso mutant.
DNA isolation and manipulation
Plasmid extractions and DNA purifications were carried 
out using standardized commercial kits (OMEGA, Bio-
Tek, Guangzhou, China). PCR reactions were carried out 
using Pfu DNA polymerase (TIANGEN, Beijing, China). 
Oligonucleotide synthesis and DNA sequencing were 
performed by Sunny Biotech company (Shanghai, China). 
Restriction endonucleases and T4 DNA ligase were pur-
chased from Fermentas (Shenzhen, China).
Genomic library construction and library screening
S. somaliensis SCSIO ZH66 genomic DNA was par-
tially digested with Sau3AI, and fragments with the size 
of 40-50  kb were recovered and dephosphorylated with 
CIAP, and then ligated into SuperCos1 that was pre-
treated with XbaI, dephosphorylated, and digested with 
BamHI. The ligation product was packaged into lambda 
particles with the MaxPlax Lambda Packaging Extract 
(Epicenter, Madison, WI, USA) as per the manufacture’s 
instruction and plated on E. coli Top10. The titer of the 
primary library was about 2 ×  106 cfu per μg of DNA. 
Specific primers were designed per the draft genome 
sequence for library screening against 2500 colonies by 
PCR (Additional file 1: Table S3).
Sequence analysis
The two type III PKSs were identified from the S. soma-
liensis SCSIO ZH66 genome using the antiSMASH 
program [31]. orf assignments and their proposed func-
tion were accomplished by using the FramePlot 4.0beta 
(http://nocardia.nih.go.jp/fp4) [32] and Blast programs 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) [33], respectively.
Gene inactivation
Gene inactivation in S. somaliensis SCSIO ZH66 was 
performed using the REDIRECT Technology according 
to the literature protocol [29, 34]. The amplified aac(3)
IV-oriT resistance cassette from pIJ773 was transformed 
into E. coli BW25113/pIJ790 containing corresponding 
cosmid to replace an internal region of the target gene. 
Mutant cosmids were constructed (Additional file  1: 
Page 8 of 9Huang et al. Microb Cell Fact  (2016) 15:116 
Table S4) and introduced into S. somaliensis SCSIO ZH66 
by conjugation from E. coli ET12567/pUZ8002 accord-
ing to the reported procedure [35]. The desired mutants 
were selected by the apramycin-resistant and kanamycin-
sensitive phenotype, and were further confirmed by PCR 
(Additional file 1: Table S5, Figures. S1, S3–S7).
Production and analyses of VLPs
The fermentation cultures were harvested by centrifuga-
tion, and the supernatant was extracted twice with an equal 
volume of ethyl acetate. The combined EtOAc extracts 
were concentrated in vacuo to afford residue A. In the case 
of the ΔwblAso mutant, the precipitated mycelia and XAD-
16 resin were extracted twice with acetone. The extracts 
were combined, and acetone was evaporated in vacuo to 
yield residue B. The combined residues (for the ΔwblAso 
mutant) or residue A (for the other mutants) were dis-
solved in MeOH, filtered through a 0.2 μm filter, and sub-
ject to HPLC. The HPLC system consisted of Agilent 1260 
Infinity Quaternary pumps and a 1260 Infinity diode-array 
detector. Analytical HPLC was performed on an Eclipse 
C18 column (5 μm, 4.6 × 150 mm) developed with a lin-
ear gradient from 5 to 80 % B/A in 40 min (for analyzing 
ΔwblAso mutant) or 20 to 70 % B/A in 20 min (for analyz-
ing all the other mutants reported here) (phase A: 0.1 % for-
mic acid in H2O; phase B: 100 % acetonitrile supplemented 
with 0.1 % formic acid) followed by an additional 10 min 
at 100 % B at flow rate of 1 mL/min and UV detection at 
290  nm. For VLPs purification, semi-preparative HPLC 
was carried out using an YMC-Pack ODS-A C18 column 
(5 μm, 120 nm, 250 × 10 mm). Samples were eluted with 
a linear gradient from 50 to 80 % B/A in 40 min, followed 
by 100 % B for 10 min at a flow rate of 2.0 mL/min and UV 
detection at 290 nm. The identity of VLPs were confirmed 
by HR-ESI–MS and NMR analysis. HR-ESI-MS was car-
ried out on Thermo LTQ-XL mass spectrometer. NMR 
data was recorded with an Agilent-DD2 500 spectrometer.
Microscopy
For scanning electron microscopy, colonies were fixed 
in 2.5  % (v/v) glutaraldehyde at 4  °C overnight, stained 
with osmic acid for 2–4  h and dehydrated with ethanol 
at different concentrations. Each sample was coated with 
platinum-gold and then detected using a Hitachi S-4800 
scanning microscope.
Biological assays
The antibacterial activity of VLPs was assayed by agar dif-
fusion test against methicillin-resistant S. aureus CCARM 
3090. The MRSA strain was seeded in LB medium and 
then incubated at 37  °C for 20 h. After dilution with LB 
to 108  cfu/mL, 25 μL of cell suspension was mixed with 
25 mL LB medium for each plate. Subsequently, 10 μL of 
VLPs, at a final concentration of 10 mg/mL, were added to 
the sample wells and the inhibition zones were observed 
after incubation at 37  °C for 20  h. For determination of 
MIC values, the VLPs solutions were prepared in metha-
nol and dispensed into 96-well plates using serial dilu-
tion method. Different concentration ranges were used 
for each compound. The overnight culture of MRSA was 
diluted to 106 cfu/mL when used. LB broth was used as a 
blank control, and methanol and tetracycline were used as 
a negative control and a positive control, respectively. The 
growth of MRSA was measured after 12 h of incubation at 
30  °C on a microplate reader (Epoch2, Biotech) at wave-
length of 600 nm. Each assay was performed in triplicate.
Transcriptional analysis by quantitative real‑time RT‑PCR
Total RNAs were prepared using Ultrapure RNA Kit 
(CWBio. Inc., Beijing, China). qPCR was performed 
as described previously [30]. The primers for qPCR are 
listed in Table S6.
Nucleotide sequence accession number
The nucleotide sequences of wblAso, pksIII-1 and the vio 
gene cluster reported in this paper have been deposited 
in the GenBank database under accession numbers of 
KU534996, KU534994 and KU534995, respectively.
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